Developmental Psychiatry Section, Department of Psychiatry, Cambridge Clinical School, University of Cambridge, and Lifespan Healthcare Trust, England
Neuroendocrine Laboratory, Department of Anatomy, University of Cambridge
Statistical Laboratory, University of Cambridge
Correspondence: Professor Ian M. Goodyer, Department of Child and Adolescent Psychiatry, University of Cambridge, Section of Developmental Psychiatry, Douglas House, 18B Trumpington Road, Cambridge CB2 4AH, UK
Declaration of interest Funding from the Wellcome Trust.
See editorial, pp. 482-483,
this issue.
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Aims To determine whether there is a specific pattern of psychoendocrine factors that predicts the onset of major depressive disorder.
Method 180 adolescents (73 boys, 107 girls) at high risk for psychopathology were assessed for cortisol, DHEA, depressive symptoms, life events and psychiatric disorder at entry and 12 months later.
Results Major depression was predicted for both genders by the additive effects of: higher depressive symptoms; personal disappointments and losses only in the month before onset; one or more daily levels of cortisol at 08.00 h or DHEA at 20.00 h greater than the 80th percentile of the daily mean.
Conclusions A subgroup of adolescents may carry a physiological risk for major depression which may be either of genetic and/or earlier psychosocial origin.
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
![]() |
METHOD |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
A life events screening questionnaire was completed by 1409 adolescents during school time, 42 being absent or unwilling. Also 1394 (99%) agreed to complete a 38-item checklist of psychological symptoms covering current mood, feelings and anxieties condensed from four questionnaires: Mood and Feelings (Kent & Vostanis, 1997), Revised Manifest Anxiety Scale (Reynolds & Paget, 1983), Rosenberg Self Esteem Scale (Rosenberg, 1965) and the Leyton Obsessional Inventory (Berg et al, 1986).
There was no difference in the mean scores for adolescents whose parents did and did not return the questionnaires: returnees (n=690), 21.3 (s.d.=11.4) v. non-returnees (n=704), 21.6 (s.d.=10.8) (t=0.4, NS). There was also no difference in the number of life events reported by adolescents whose parents did or did not return forms (two or more events: returnees 410/690 (59%) v. non-returnees 411/704 (58%)). Since there were no parent data from non-returnees, any ascertainment bias on demographic features or family characteristics is not known. From this population subjects were chosen who met criteria for high risk for psychopathology.
Definition of high risk
Recent undesirable life events exert their greatest risk when they occur as
additive experiences in multiples greater than 2 over the previous 12 months
(Goodyer, 1995). Since it is
not known which combination of risk factors is most likely to result in
subsequent onsets, a range of risks were combined in the screen procedure. A
subject at high risk was defined as any adolescent with two or more risk
factors from the following list:
In addition, the presence of a history of parental psychiatric disorder by itself qualified as high risk.
Exclusion criteria were: adolescents with chronic and potentially life-threatening medical illnesses, including epilepsy, cancer, heart disease; learning difficulties that required formal special educational assistance (n=5); or limited understanding of English (n=3). There were no subjects with a potentially life-threatening illness.
Study entrants
Informed consent was given by 180 of the 250 invited (72%). There were no
differences in risk factors, age or gender between those who consented and
those who did not.
At entry all subjects completed a semi-structured interview, the KiddieSADS (Schedule for Affective Disorders and Schizophrenia) patient version (Kaufman et al, 1997), to ascertain whether the subject had been free of mental illness over the previous 3 months. This assessment took place within 4 to 8 weeks of the screen procedures. Seven subjects were excluded. Individuals with depressive symptoms but without social or personal impairment were not excluded. One subject subsequently withdrew. Subjects were classified as either pre- or post-pubertal (Tanner stage > 1). One hundred and seventy-one subjects (age 12 years 2 months to 16 years 6 months mean 13 years 6 months), completed both psychosocial and endocrine assessments at follow-up.
The current medications of all eligible subjects were recorded. Neither beta-methasone nor salbutamol had a significant effect on either salivary cortisol or DHEA levels (Goodyer et al, 2000).
Measures
Subjects completed a semi-structured psychosocial interview evaluating
recent undesirable and desirable life events and friendships
(Goodyer et al, 1997).
The onset of each event that had occurred over the previous 12 months was
dated to within 4 weeks. Undesirable events (those carrying a moderate to
severe degree of negative impact) were categorised into four mutually
exclusive groups as follows:
Mood and Feelings Questionnaire
The self-report questionnaire on recent depressive symptoms used was the
Mood and Feelings Questionnaire (MFQ), which is designed to cover the symptom
areas as specified in DSMIV
(American Psychiatric Association,
1994) for MDD in children
(Kent & Vostanis,
1997).
Other self-reports used at baseline in this population for current anxious and obsessional symptoms, ruminative cognitive style and lower self-esteem, have already been shown to exert no significant independent effects on onset of subsequent major depression, once the effects of high depressive symptoms have been taken into account (Goodyer et al, 2000).
Saliva samples
Subjects provided samples of saliva at 08.00 h and 20.00 h over 4
consecutive days within a week of the interview. They were instructed not to
clean their teeth but to wash out their mouths before taking samples. Saliva
was dribbled directly into plastic tubes, without using aids to salivation or
swabs. Samples were stored in the subject's own freezer at less than
0°C.
Reassessment at 12 months
A positive response on the KiddieSADS short interview resulted in
the full psychiatric assessment (n=48 of 171). An episode of major
depression was deemed present if at any time over the previous 12 months a
subject met DSMIV criteria. Life events were re-evaluated, thereby
giving a 24-month period (12 months before entry and a further 12 up to
reassessment) over which events had been recorded. For those subjects who
subsequently developed major depression, events were divided into before and
after onset of the episode. Onset was taken as the best point estimate to the
nearest week from the date of the interview, when depressive signs and
symptoms were present and resulted in discernible worsening in personal and/or
social functioning.
Onsets occurred throughout the 11 months after the first month of entry into the study. Thus, the 12-month period counted before onset is not the same 12 months for every case, although there is > 80% overlap in the time period covered for all cases. The event data in the cases is compared with the events that occurred in the non-cases group for the 12 months between entry and follow-up. The timing of events for non-cases was taken as the number of months prior to the date of reassessment.
Hormone measures
Each sample was assayed separately for cortisol and DHEA. Cortisol was
measured by enzyme-linked immunosorbent assay (ELISA) on 20 µl samples of
saliva without extraction (antibody Cambio, Cambridge, UK). Intra-assay
variation was 5.7%; inter-assay variation was 5.6%. Dehydroepiandrosterone was
measured by validated radioimmunoassay on 333 µl samples after extraction
into hexane/ether (4:1) (antibody Bioclin, Cardiff, UK). Intra-assay variation
was 5.1%, inter-assay variation was 7.4%. There is a good correlation between
plasma and salivary levels for both steroids (Pearson's r=0.6 for
cortisol; 0.9 for DHEA (Goodyer et
al, 1996). Results are reported in ng/ml.
There were two indices of endocrine activity. The mean level of steroid at each time point was calculated from the four values obtained from each subject. This gave four indices at entry, and another four at follow-up (mean cortisol and DHEA at 08.00 h and 20.00 h).
A second index was also used, derived following a reconsideration of how best to reflect individual variation in hormone dynamics in samples collected over 4 days. This was based on whether or not a peak value of a steroid occurred in any of the four samples. A peak was defined a priori as an extreme level, taken as > 80th percentile of the mean. Subjects were classified as peak positive if they had one or more level greater than the 80th percentile of the daily mean of the group on 1 or more days of the 4-day sampling period.
The 80th percentile level for cortisol was calculated for males and females separately. For DHEA the 80th percentile was calculated for each age (in years 12-16) as well as for each gender.
Statistical analysis
Group comparisons were carried out using exact statistics for categorical
data, and Bonferroni-corrected analysis of variance on log-transformed
continuous data. Subjects were grouped for age and gender at entry and
conditional fixed-effects logistic regression was used to determine the best
fit for psychoendocrine variables that predicted the subsequent onset of major
depression.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Onset of MDD
Thirty (18%) of the 171 reassessed subjects had experienced an onset of
DSMIV major depression over the follow-up period (cases). The remainder
(non-cases) did not meet DSMIV criteria for MDD during the follow-up
period.
Life events
Burden of events
A comparison was made between the proportion of cases and non-cases who
experienced none to four undesirable events focused on the self, prior to
onset (MDD cases) or in the 12 months' follow-up (non-MDD cases). There were
no differences between the groups overall, or analysed separately for males
and females: overall, MDD cases v. non-MDD cases: none (3 (10%)
v. 15 (11%)), one (9 (30%) v. 51 (36%)), two (11 (37%)
v. 50 (35%)), three (7 (23%) v. 21 (15%)), four or more (0
v. 4 (3%)), exact test, P=0.781, indicating no association
between the general burden of events and onset of major depression. There was
no effect of age for either gender.
Timing of events
The frequency of moderate to severe undesirable events per month was <1
for both MDD cases and non-MDD cases. Events were therefore classified into
four temporal groups: 1 month; 2-3 months; 4-6 months and 7-12 months,
respectively, before onset (cases) or before follow-up (non-cases). The
proportions of cases and non-cases who experienced one or more of any type of
undesirable event in each time period is different between the two groups
(2(3)=16.08, P=0.0011).
MDD cases were more likely than non-MDD cases to experience events in the preceding month only (18/30 (60%) v. 31/141 (22%), exact test, P=0.0001, odds ratio 5.4; 95% CI 2.4-12.2). There were no gender differences in those reporting one or more events in this 1-month period. By contrast, significantly more girls than boys reported experiencing one or more events over the rest of the 2- to 12-month period (exact test, P=0.028, odds ratio=2.5; 95% CI 1.17-5.49).
Types of events
A conditional fixed-effects logistic regression was carried out to
determine the best fit between the type and timing of events and subsequent
MDD. The results are shown in Table
1.
|
Only disappointments and permanent losses in the first month before interview/onset were associated with subsequent MDD. The analysis was repeated with the total number of events over the 12 months as a further factor. There was no change in the final model (total number of events OR=1.1, P=0.824). The analysis reported in Table 1 was repeated, excluding dangers to others (i.e. focusing on self-related events only). The findings remained the same.
Hormones
Mean levels
There was a large diurnal variation in mean cortisol (am:pm ratio 12:8) and
a much smaller one in DHEA (am:pm ratio 2:1). Mean salivary cortisol was
higher in girls than boys at 08.00 h (F(1172)=6.24, P=0.013
(Bonferroni)) but not at 20.00 h. Mean salivary DHEA was also higher in girls
than boys at 08.00 h (F(1164)=6.23, P=0.014) and at 20.00 h
(F(1164)=4.23, P=0.041). Age was a significant covariate in
both the DHEA analyses (levels of DHEA increase with age).
Peaks
The proportions of peak-positive subjects (yes/no) for cortisol and DHEA
are shown in Table 2, together
with average mean levels over 4 days. The findings show that there were no
significant differences in the proportion of peak-positive subjects at 08.00 h
for either hormone in either males or females.
|
Those who were peak-positive for cortisol at 08.00 h and 20.00 h were significantly older than those who were not (08.00 h, 13.99 (s.d.=1.22) v. 13.53 (s.d.=1.14) F(1172)=6.25, P=0.013 (Bonferroni); 20.00 h, 14.98 (s.d.=1.21) v. 13.54 (s.d.=1.15) F(1172)=5.01, P=0.017 (Bonferroni). There were no age differences between DHEA peak-positive and peak-negative groups.
For cortisol, 71 (41.3%) had no peaks at either time point, 32 (18.6%) had morning only, 27 (15.7%) evening only, and 42 (24.4%) had both. For DHEA, the figures were 112 (67%), 18 (11%), 25 (15%) and 11 (7%), respectively. There were no significant differences in these proportions between males and females. There was no association between the proportions of subjects who were cortisol and DHEA peak-positive at either time point.
Peak hormones, life events and depressive symptoms at entry
There were no associations between peak positive status and any type of
event either at 1 month or 2-12 months before onset or during follow-up.
Neither were there any associations with the number of events. Mean scores on
the MFQ scale were not significantly different between peak-positive and
peak-negative groups for cortisol or DHEA at either time point.
Peak hormones, life events and subsequent MDD
Comparisons were made between MDD cases and non-MDD cases for the
proportion of subjects with peak hormones. A significant association was found
for peak cortisol at 08.00 h (18/28 (64%) v. 52/137 (38%), exact test
P=0.012, odds ratio 2.9, 95% CI 1.3-6.7), and peak DHEA at 20.00 h
(11/27 (41%) v. 25/136 (18%), exact test P=0.02, odds ratio
3.0, 95% CI 1.3-7.3) at entry, and subsequent MDD.
A conditional fixed-effects logistic regression was computed with case/non-case as the response variable and life events at one month, mood and feelings scores at entry, mean salivary cortisol and DHEA at both time points at entry, as the predictors. This showed that only disappointing and loss events contributed to the model. A second model was computed replacing the absolute hormone levels with the binary variable (peaks yes/no) for cortisol and DHEA at both time points. This model is shown in Table 3.
|
The findings show that the onset of subsequent MDD is associated with being cortisol peak-positive at 08.00 h (OR=7.1; P=0.008, 95% CI=1.67-30.4); and DHEA peak-positive at 20.00 h (OR=4.2, P=0.02, 95% CI=1.2-14.7). The effects of both disappointments and loss events in the one month closest to onset remain highly significant, with higher self-report mood and feeling scores also being retained. The relationship between mean levels and peaks for both hormones was further examined by repeating these analyses with both means and peaks in the model. Absolute levels of either hormone did not contribute to this model.
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
A previous paper showed that the onset of MDD occurs in >90% of cases from the high-risk population with antecedent ongoing psychosocial adversities (Goodyer et al, 2000). Thus, both long-standing and highly proximal psychosocial adversities contribute to onset in this adolescent population. This social model is similar to that previously described for adults and high-school students (Brown et al, 1987; Lewinsohn et al, 1998).
Of the 30 episodes of MDD over the 12-month period, only 16 (53%) were preceded by either a disappointing or a loss event. Thus, nearly half of the episodes arise in high-risk individuals who are not exposed to these immediate proximal experiences. Provided that the recognition of proximal events is accurate, this suggests that there may be other factors predisposing to disorder.
Antecedent depressive symptoms
A post hoc examination of the characteristics of this high-risk
sample showed no difference in MFQ scores at entry between those onsets with
identified proximal events (events-driven) 26.47 (s.d.=11.77)
and those without 23.2 (s.d.=7.47). There were no differences in the
psychosocial risk profiles of the two groups. Neither were event-driven cases
significantly older or more likely to be girls.
However, there are additive effects between current mood at entry and the impact of proximal life events, further confirming that higher levels of depressive symptoms are associated with subsequent onset of MDD in this high-risk group (Lewinsohn et al, 1995). In a recent longitudinal study, depressive symptoms over 4 years increased the risk for internalising disorder, with parent-child disagreements exerting their effects indirectly by increasing the level of depressive symptoms over time (Rueter et al, 1999). It is possible that the non-event-driven cases occurring in the high-risk sample reported in this paper had increasing internalising symptoms over the 12-month follow-up period and are examples of slower-onset disorder with no provoking proximal events. This leads to the tentative conclusion that highly proximal events may exert their psychopathological effects by increasing an already rising level of depressive symptoms above clinical threshold.
Peak hormones and subsequent MDD
The second set of questions related to the putative role of cortisol and
DHEA in the onset of major depression. It has already been suggested that mean
salivary DHEA at 08.00 h is associated with subsequent MDD in a combined
analysis of both low-and high-risk adolescents
(Goodyer et al,
2000). This paper introduces a second index of antecedent hormone
activity, defined as whether or not a subject had a peak that
lay at or above the 80th percentile of the mean value for the group for each
gender (and age for DHEA). This type of measure has been used to estimate
variability or reactivity in cortisol in children
(Gunnar, 1998). Measuring
peaks gives a different perspective on endocrine function from determining
mean values. The latter will not delineate subjects with extreme day-to-day
variation of either hormone. Peak, rather than basal salivary levels, may thus
reflect an additional peripheral index of
hypothalamicpituitaryadrenal axis dysregulation. Cortisol has a
lower affinity for type 2 than type 1 corticoid receptors and a distinct
population of these receptors might be activated by peak levels
(Reul & de Kloet, 1985).
There are also specific type 2 associated effects such as those on glucose
transport, and suppressant effects on neuronal excitability
(Joels & de Kloet, 1994).
Measures reflecting steroid reactivity may be an additional index of
psychological difficulty in young people. For example, in well children it is
morning cortisol levels in the highest interquartile range, rather than the
daily mean, that are associated with a solitary and negative affective
behavioural style (Gunnar,
1998).
This paper shows, for the first time, that the occurrence of peaks in morning cortisol is predictive of subsequent MDD in high-risk adolescents. Peaks in evening DHEA were also associated with subsequent MDD. There is no relation between peaks for either hormone, higher self-report depression scores and the occurrence of life events, further suggesting that these factors may be independent. Peaks were also more likely in older high-risk adolescents of either gender. The origins of individual variation in peak levels for both hormones may arise in more distal adverse environments and/or from genetic influences.
The validity of the peak measure requires further investigation. Only 4 days of saliva collection was undertaken and it is unclear whether this is sufficient to obtain a representative sample of subjects liable to peak levels. It also remains to be determined whether peaks in morning cortisol and evening DHEA are of psychopathological significance only in high-risk adolescents.
Hormone reactivity to environmental demands
The current design is not an adequate test of a possible physiological
reactivity model where hour-to-hour variation can be a function of minor
events or hassles in people's lives rather than major events in recent weeks.
Such rapid changes require measurement of hormones before and within 30-60
minutes or so after the stimulus. There is evidence that cortisol reactivity
does occur when subjects are put into stressful circumstances, particularly
those that are associated with an increase in negative mood
(van Eck et al,
1996). There is also evidence suggesting an association between
higher cortisol levels and specific impairments in verbal declarative memory,
implying a potential neural basis for the effect of cortisol peaks on the
liability for psychopathology (Newcomer
et al, 1999). Whether DHEA exhibits similar demand
characteristics of this nature is not known. The functional effects of steroid
variability on everyday cognitive performance, and particularly memory, in
at-risk populations require further investigation.
Puberty, hormones and subsequent MDD
There may be a second set of endocrine risk factors for MDD associated with
puberty. For example, it is postulated that rising levels of testosterone
and/or oestrogen are themselves related to increased risk for MDD in girls
(Angold et al, 1999).
Since nearly all our subjects were post-pubertal, we cannot assess this risk
in relation to that presented by peaks in cortisol or DHEA. As for the latter,
it is well known that DHEA levels increase during puberty in both boys and
girls, whereas cortisol levels remain relatively unaltered
(Kroboth et al, 1999; Parker, 1999). Levels of (or
peaks in) DHEA may, therefore, be another endocrine index of maturation, and
this may account for the relationship we find between DHEA and subsequent MDD.
The findings in this paper suggest a putative causal role for cortisol and
DHEA that is not a consequence of highly proximal recent life events or
subclinical depressive symptoms. Further research into the origins of
individual differences in steroid variability for each gender is required.
![]() |
Clinical Implications and Limitations |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
LIMITATIONS
![]() |
ACKNOWLEDGMENTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Angold, A., Costello, E. J., Erkanl, A, et al (1999) Pubertal changes in hormone levels and depression in girls. Psychological Medicine, 29, 1043-1053.[CrossRef][Medline]
Berg, C., Rapoport, J. & Flament, M. (1986) The Leyton Obsessional Inventory Child Version. Journal of the American Academy of Child and Adolescent Psychiatry, 25, 84-91.
Brown, G. W., Bifulco, A. & Harris, T. O. (1987) Life events, vulnerability and the onset of depression: some refinements. British Journal of Psychiatry, 150, 30-42.[Abstract]
Buss, A. & Plomin, R. (1984) Temperament: Early Developing Personality Traits. Hillsdale, NJ: Lawrence Erlbaum.
Goodyer, I. M. (1995) Life events and difficulties: their nature and effects. In The Depressed Child and Adolescent: Developmental and Clinical Perspectives (ed. I. Goodyer), pp. 171-193. Cambridge: Cambridge University Press.
Goodyer, I. M. & Altham, P. M. E. (1991) Lifetime Exit Events in anxiety and depression in school age children: I. Journal of Affective Disorders, 21, 219-228.[CrossRef][Medline]
Goodyer, I. M., Herbert, J., Altham, P. M. E., et al (1996) Adrenal secretion during major depression in 8 to 16 year olds. I: Altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation. Psychological Medicine, 26, 245-256.[Medline]
Goodyer, I. M., Herbert, J., Tamplin, A., et al (1997) Short-term outcome of major depression. II. Life events, family dysfunction and friendship difficulties as predictors of persistent disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 474-480.[Medline]
Goodyer, I. M., Herbert, J., Tamplin, A., et al
(2000) First-episode major depression in adolescents.
Affective, cognitive and endocrine characteristics of risk status and
predictors of onset. British Journal of Psychiatry,
176,
142-149.
Gunnar, M. R. (1998) Quality of early care and buffering of neuroendocrine stress reactions: potential effects on the developing human brain. Preventative Medicine, 27, 208-211.[CrossRef][Medline]
Joels, M. & de Kloet, E. R. (1994) Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems. Progress in Neurobiology, 43, 1-36.[CrossRef][Medline]
Kaufman, J., Birmaher, B., Brent, D., et al (1997) Schedule for affective disorders and schizophrenia for school-age children present and lifetime version (K-SADS-PL): initial reliability and validity data. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 980-988.[Medline]
Kent, L. & Vostanis, P. (1997) Detection of major and minor depression in children and adolescents: evaluation of the Mood and Feelings Questionnaire. Journal of Child Psychology and Psychiatry, 38, 566-573.
Kroboth, P. D., Salek, F. S., Pittenger, A. L., et al
(1999) DHEA and DHEAS: a review. Journal of
Clinical Pharmacology, 39,
327-348.
Lewinsohn, P. M., Gotlib, I. & Seeley, J. R. (1995) Adolescent psychopathology: IV. Specificity of psychosocial risk factors for depression and substance abuse in older adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 1221-1229.[Medline]
Lewinsohn, P. M., Rohde, P. & Seeley, J. R. (1998) Major depressive disorder in older adolescents: prevalence, risk factors, and clinical implications. Clinical Psychology Review, 18, 765-794.[CrossRef][Medline]
Lewis, D. A. & Smith, R. E. (1983) Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. Journal of Affective Disorders, 5, 319-332.[CrossRef][Medline]
Newcomer, J. W., Selke, G., Melson, A. K., et al
(1999) Decreased memory performance in healthy humans induced
by stress-level cortisol treatment. Archives of General
Psychiatry, 56,
527-533.
Parker, C. R. (1999) Dehydroepiandrosterone and dehydroepiandrosterone sulfate production in the human adrenal during development and aging. Steroids, 64, 640-647.[CrossRef][Medline]
Peterson, A. C., Sarigiani, P. A. & Kennedy, R. E. (1991) Adolescent depression: why more girls? Journal of Youth and Adolescence, 20, 247-271.
Reul, J. M. & de Kloet, E. R. (1985) Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology, 117, 2505-2511.[Abstract]
Reynolds, C. & Paget, K. (1983) National normative and reliability data for the revised children's manifest anxiety scale. School Psychology Review, 12, 324-336.
Rosenberg, M. (1965) Society and the Adolescent Self Image. Princeton, NJ: Image.
Rueter, M. A., Scaramella, L., Wallace, L. E., et al
(1999) First onset of depressive or anxiety disorders
predicted by the longitudinal course of internalizing symptoms and
parentadolescent disagreements. Archives of General
Psychiatry, 56,
726-732.
van Eck, M., Berkhof, H., Nicolson, N., et al (1996) The effects of perceived stress, traits, mood states, and stressful daily events on salivary cortisol. Psychosomatic Medicine, 58, 447-458.[Abstract]
Received for publication January 19, 2000. Revision received June 19, 2000. Accepted for publication June 20, 2000.